Trials / Completed
CompletedNCT04953039
Use of Saliva for COVID-19 Diagnosis
Use of Saliva for Diagnosis of SARS-CoV2 Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 109 (actual)
- Sponsor
- University of Milano Bicocca · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aim of the study is to evaluate the presence of SARS-CoV2 RNA in the saliva of patients with suspected or confirmed COVID-19 in order to validate the analysis of this type of sample for the diagnosis of SARS-CoV2 infections.
Conditions
Timeline
- Start date
- 2020-11-19
- Primary completion
- 2021-10-12
- Completion
- 2021-10-12
- First posted
- 2021-07-07
- Last updated
- 2022-07-26
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04953039. Inclusion in this directory is not an endorsement.